Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 50% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM) shares were up 50% on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares traded hands during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Performance

The stock has a market cap of C$14.64 million, a P/E ratio of -10.50 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a 50 day simple moving average of C$0.07 and a 200 day simple moving average of C$0.06.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.